Maunjaro side effects, effects, and price summary | Comparison with Wegobi and insurance coverage

The hottest name in the diet and diabetes treatment market these days is Mounjaro.

In the United States, it has become a hot topic for its blood sugar control and weight loss effects.
As news of its domestic launch spreads, curiosity and concern about the side effects of Maunjaro are also growing.

 

In this article, we will cover the effects of Maunjaro, the price of Maunjaro, and the domestic release schedule of Maunjaro.
And comparing the cost of the insurance and whether it is covered by insurance,
Lastly, we will provide a detailed explanation of the side effects of Maunzaro, which many people are most curious about.

What is Maunjaro?

 

Maunjaro (ingredient name: Tirzepatide)
It is a dual agonist that simultaneously stimulates GLP-1 receptor agonist (GLP-1 RA) and GIP receptor agonist.

It was originally developed as a treatment for type 2 diabetes,
In addition to blood sugar control, it has been proven in clinical trials to have a powerful weight loss effect.
It is also attracting attention for the purpose of treating obesity.

 

Maunjaro effect

 

1. Blood sugar control
- Promotes insulin secretion
- Inhibition of glucagon (a hormone that raises blood sugar) secretion
- Suppresses postprandial blood sugar rise

 

2. Weight loss
- Appetite suppression + slow gastric emptying
- SURMOUNT-1 study: Average 20% weight loss over 72 weeks (based on the 15 mg high dose)

 

3. Potential improvement in cardiovascular risk
- Some studies have reported trends in improving blood pressure, triglycerides, and HDL.

 

Maunjaro Side Effects – Detailed Analysis

 

The side effects of Maunjaro are similar to those of Wigobi (semaglutide), but
It has been reported that due to the dual action of GLP-1 + GIP, the side effects may be as strong as the effects.

 

1. Gastrointestinal side effects (most common)

- Nausea and vomiting: Most common between 1 and 4 weeks after starting the medication.
- Diarrhea and constipation: Caused by changes in gastric emptying speed
- Abdominal bloating and heartburn: Caused by slowed gastric motility
- Excessive appetite suppression: Rapidly reduced food intake, leading to risk of malnutrition

 

Coping:
- Lower the initial dose and increase slowly over 4 to 6 weeks
- Avoid oily and high-sugar foods
- Eat small amounts frequently

 

2. Pancreatic and gallbladder-related side effects

 

- Acute pancreatitis: Extremely rare but serious; stop immediately if you experience sudden upper abdominal pain or vomiting.
- Gallbladder disease (gallstones, cholecystitis): Possibility of bile stasis with long-term use

 

Coping:
- If accompanied by abdominal pain, fever, or vomiting, visit the hospital immediately.
- If you have a history of pancreatitis or gallbladder disease, you must consult a doctor.

 

3. Hypoglycemia

 

- Rare when used alone, but increased risk when used in combination with insulin and sulfonylurea
- Dizziness, cold sweat, hand tremors, and blurred vision may occur.

 

Coping:
- If you experience symptoms of hypoglycemia, immediately consume sugar (candy, juice)
- Diabetic patients should check their blood sugar level regularly using a blood sugar meter.

 

4. Other reported side effects

• 
  - Dehydration/electrolyte imbalance: When vomiting/diarrhea is severe
  - Skin reaction: redness and itching at the injection site
  - Headache and fatigue: May occur during the initial adaptation period.
  - Hair changes: Reports of possible telogen effluvium with rapid weight loss

 

Risk group for side effects of Maunjaro

• 
  - People with a history of pancreatitis or gallbladder disease
  - Patients with severe gastrointestinal diseases (e.g., gastroparesis)
  - Patients with renal failure or liver disease
  - Patients taking insulin and sulfonylurea together
  - Pregnant and breastfeeding women

 

Domestic release and price of Maunjaro

• 
  - Expected domestic release: Second half of 2025
  - Price for Maunjaro: US$1,000 per month (approximately 1.3 million won) → The initial domestic price is expected to be 600,000 to 800,000 won per month.
  - Initially, prices may fluctuate due to limited import volume.
•  

Maunjaro vs. Wigobi comparison

item	Maunjaro	Wegobi
ingredient	Tirzepatide	Semaglutide
How it works	GLP-1 + GIP dual action	GLP-1 single-acting
average weight loss	~20% (15mg)	~15% (2.4mg)
side effect	Gastrointestinal symptoms, pancreatitis, gallbladder disease, hypoglycemia	Gastrointestinal symptoms, pancreatitis, gallbladder disease
Dosage cycle	Subcutaneous injection once a week	Subcutaneous injection once a week

 

 

Whether insurance applies to Maunjaro

- For the purpose of obesity treatment: Currently not covered by domestic insurance
- For the treatment of type 2 diabetes: Some insurance coverage is possible.
- If not covered, the patient's share is high, and the financial burden must be considered when taking the medication for a long period of time. 

conclusion

The side effects of Maunjaro are similar to those of Wegobi, but because the effect is stronger, discomfort may be more noticeable during the initial adaptation period.

Gastrointestinal symptoms are the most common, but there are also rare but serious side effects such as pancreatitis and gallbladder disease.

Be sure to check your health status before taking it.
It is safe to start after learning how to deal with side effects that may occur.
It is advisable to make a long-term plan that takes into account price and insurance coverage.

 

 

 

Click here to see more related articles on Maunjaro!

✅Maunjaro Review｜I tried it first in the US! Discover the benefits, price, and direct purchase tips.

✅Complete review of Maunjaro in Japan | Effects, side effects, and reactions